Tilray, Inc.
(NASDAQ : TLRY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.03%185.181.3%$523.73m
ARRYArray BioPharma Inc.
0.41%46.398.1%$429.55m
CELGCelgene Corporation
-5.42%93.551.3%$409.28m
GILDGilead Sciences, Inc.
-0.85%68.790.9%$404.55m
BIIBBiogen Inc.
-1.31%235.951.3%$375.90m
ILMNIllumina, Inc.
-0.74%358.893.5%$305.58m
REGNRegeneron Pharmaceuticals, Inc.
-2.67%311.712.6%$245.37m
VRTXVertex Pharmaceuticals Incorporated
-1.60%181.021.9%$225.25m
ALXNAlexion Pharmaceuticals, Inc.
-4.45%126.502.0%$202.14m
EXASExact Sciences Corporation
-1.08%114.4124.1%$195.17m
AAgilent Technologies, Inc.
-0.40%73.051.6%$181.50m
BMRNBioMarin Pharmaceutical Inc.
-2.75%85.504.3%$129.53m
INCYIncyte Corporation
-2.12%86.822.5%$116.17m
SRPTSarepta Therapeutics, Inc.
-1.36%128.1114.7%$112.84m
MRTXMirati Therapeutics Inc.
0.18%101.622.5%$102.16m

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.